Vinik AI, Arora RR, Colombo J. Age matched attenuation of both autonomic branches in chronic disease: II. Diabetes Mellitus. Cleveland Clinic Heart-Brain Summit, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas; 23–24 Sept 2010.
Arora RR, Ghosh-Dastidar S, Colombo J. Age matched attenuation of both autonomic branches in chronic disease: I. Hypertension. Presented at the Cleveland Clinic Heart-Brain Summit, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas; 23–24 Sept 2010.
Arora RR, Ghosh-Dastidar S, Colombo J. Age matched attenuation of both autonomic branches in chronic disease: III. Coronary Artery Disease. Presented at the Cleveland Clinic Heart-Brain Summit, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas; 23–24 Sept 2010.
Nemechek P, Ghosh-Dastidar S, Colombo J. Age matched attenuation of both autonomic branches in chronic disease: IV. HIV/AIDS. Presented at the Cleveland Clinic Heart-Brain Summit, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas; 23–24 Sept 2010.
Gentlesk PJ, Wiley T, Taylor AJ. A prospective evaluation of the effect of Simvastatin on heart rate variability in non-ischemic cardiomyopathy. Am Heart J. 2005;150:478–83.
Arora RR, Ghosh Dastidar S, Colombo J Autonomic balance is associated with decreased morbidity. American Autonomic Society, 17th international symposium, Kauai; 29 Oct–1 Nov 2008.
Pereira E, Baker S, Bulgarelli RJ, Murray G, Arora RR, Colombo J. Gender differences in longevity and sympathovagal balance. Presented at the Cleveland Clinic Heart-Brain Summit, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas; 23–24 Sept 2010.
Bloomfield DM, Kaufman ES, Bigger Jr JT, Fleiss J, Rolnitzky L, Steinman R. Passive head-up tilt and actively standing up produce similar overall changes in autonomic balance. Am Heart J. 1997;134(2 Pt 1):316–20.
Vinik AI, Aysin B, Colombo J. Enhanced frequency domain analysis identifies early autonomic dysfunction that may lead to elevated blood pressure in diabetics. Diabetes Technology conference, San Francisco; 10–12 Nov 2005.
Nanavati SH, Bulgarelli RJ, Vazquez-Tanus J, Ghosh-Dastidar S, Colombo J, Arora RR. Altered autonomic activity with atrial fibrillation as demonstrated by non-invasive autonomic monitoring. US Cardiol. 2010;7(1):47–50.
Colombo J, Jacot J, Aysin E, Aysin B, Iffrig K, Vinik AI. Symptoms of orthostasis may be due to sympathetic/parasympathetic autonomic imbalance and can be evaluated by hrv with respiratory analysis with appropriate pathogenesis oriented therapeutic choices. International Symposium on Diabetes Neuropathy, 7th Annual Congress, Cape Town, South Africa, 29 Nov–2 Dec 2007.
Arora RR, Ghosh Dastidar S, Colombo J. Altered sympathetic and parasympathetic activity is associated in patients with chronic coronary artery disease. Clin Auton Res. 2008;18(5):277.
Arora RR, Gosh Dastidar S, Colombo J. Age matched attenuation of autonomic activity in both branches in chronic hypertension. American Autonomic Society, 17th International Symposium, Kauai; 29 Oct–1 Nov 2008.
Karpen J, Ortiz R, Shoemaker WC. Parasympathetic and sympathetic monitoring in pain management. Online publication at Pain.com. Accessed 14 Jan 2010.
Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125:2309–21.
Sovani MP, Whale CI, Tattersfield AE. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. Drug Saf. 2004;27(10):689–715.
Tobias H, Vinitsky A, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic nervous system monitoring of patients with excess parasympathetic responses to sympathetic challenges – clinical observations. US Neurol. 2010;5(2):62–6.
Stoupakis G, Colombo J, Rendas-Baum R, Budhwani N, Arora R. Postural drop of low frequency component of heart rate variability in diagnosis of orthostasis. Presented at Scientific Sessions of the American Heart Association, Chicago; 2002.
Curtis BM, O’Keefe JH. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc. 2002;77:45–54.
Narkiewicz K, Montano N, Cogliati C, van de Borne PJH, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998;98:1071–7.
Vinik AI, Maser RE, Ziegler D. Neuropathy. The crystal ball for cardiovascular disease. Diabetes Care. 2010;33(7):1688–90.
Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, Genuth MS, Grimm RH, Corson MA, Prineas R, ACCORD Study Group. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33:1578–84.
Calles-Escandon J, Lovato L, Simons-Morton D, Kendell D, Pop-Busui R, Cohen R, Bonds D, Fonseca V, Ismail-Beigi F, Banerji M, Failor A, Hamilton B. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics. Diabetes Care. 2010;33:721–7.
Vinik AI, Murray GL. Autonomic neuropathy is treatable. US Endocrinol. 2008;2:82–4.
Vinik AI, Maser RE, Nakave AA. Diabetic cardiovascular autonomic nerve dysfunction. US Endocr Dis. 2007;2:2–9.
Vinik A, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115:387–97.
Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail. 2005;11(9):693–9.
Fatoni C, Raffa S, Regoli F, Giraldi F, La Rovere MT, Prentice J, Pastori F, Fratini S, Salerno-Uriarte JA, Klein HU, Auricchio A. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J Am Coll Cardiol. 2005;46(10):1875–82.
Barefoot JC, Helms MJ, Mark DB, Blumenthal JA, Califf RM, Haney TL, O’Connor CM, Siegler IC, Williams RB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613–7.
Davidson KW, Rieckmann N, Lesperance F. Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence. Psychosom Med. 2004;66:165–73.
Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, Newman MF. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med. 2004;66:305–15.
Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M, Bourassa MG. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919–24.
Lespérance F, Frasure-Smith N, Juneau M, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160(9):1354–60.
Joynt KE, Whellan DJ, O’Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry. 2003;54:248–61.
Pereira E, Baker S, Bulgarelli R, Arora RR, Ghosh Dastidar S, Colombo J. Autonomic imbalance may underlie labile hypertension: I Possible remedy. Clin Auton Res. 2010;20(5):318.
Baker S, Pereira E, Bulgarelli R, Arora RR, Ghosh Dastidar S, Colombo J. Autonomic imbalance may underlie labile hypertension: II Possible physiology. Clin Auton Res. 2010;20(5):319.
Prendergast JJ. Diabetic autonomic neuropathy: part 1 early detection. Pract Diabetol. 2001;20(1):7–14.
Prendergast JJ. Diabetic autonomic neuropathy: part 2 treatment. Pract Diabetol. 2001;20(2):30–6.
Lachmann J, Banerjee A, Davoudi M, Aragon D, Talerja A, Sonnenblick EH, Shirani J, Le Jemtel T. Withdrawal of angiotensin receptor blocker from triple neurohormonal therapy partially restores sympathetic activity in chronic heart failure. American Heart Association, Scientific Sessions, Anaheim; 11–14 Nov 2001.
Low PA, Engstrom JW. Disorders of the autonomic nervous system. In: Harrison’s principles of internal medicine. 16th ed. New York: McGraw-Hill; 2003.
Malik M, The Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–65.
American Heart Association web site, www.americanheart.org, 2010.
American Diabetes Association web site, www.diabetes.org, 2010.
Joint Editorial Statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association. Diabetes mellitus: a major risk factor for cardiovascular disease. Circulation. 1999;100:1132–3.
Grundy SM, Benjamin IJ, Burke GL, Chait A. AHA scientific statement: diabetes and cardiovascular disease, a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.
Aring AM, Jones DE, Falko JM. Evaluation and prevention of diabetic neuropathy. Am Fam Phys. 2005;71:2123–30.
Boulton AJM, Vinik AI, Arrezzo JC, Bril V, Feldman EI, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–62.
Low PA and the Therapeutics and Technology Assessment Subcommittee. Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46:873–80.
Arora RR, Aysin E, Aysin B, Colombo J. Therapeutic implications of sympathetic stimulus in orthostatic patients: measured by spectral domain analysis. AHA Scientific Sessions, Orlando, FL, 4–7 Nov 2007.
Robertson D, Bisggioni I, Burnstock G, Low PA, Paton JFR, editors. Primer on the autonomic nervous system. 3rd ed. Waltham: Academic; 2012.
Saper CB. Autonomic disorders and their management. In: Cecil textbook of medicine. 22nd ed. Philadelphia: WB Saunders; 2003.
Low PA, editor. Clinical autonomic disorders: evaluation and management. Philadelphia: Lippincott-Raven; 1997.
Arora RR, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic mechanisms and therapeutic implications of postural diabetic cardiovascular abnormalities. J Diabetes Sci Technol. 2008;2(4):568–71.
Waheed A, Ali MA, Jurivich DA, et al. Gender differences in longevity and autonomic function. Presented at the Geriatric Medicine Society Meeting, Chicago; 3–7 May 2006.
Fathizadeh P, Shoemaker WC, Woo CCJ, Colombo J. Autonomic activity in trauma patients based on variability of heart rate and respiratory rate. Crit Care Med. 2004;32(5):1300–5.
Chen JY, Fung JW, Yu CM. The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol. 2006;17 Suppl 3:S2–7.
Copie X, Lamaison D, Salvador M, Sadoul N, DaCosta A, Faucher L, Legal F, Le Heuzey JY, VALID Investigators. Heart rate variability before ventricular arrhythmias in patients with coronary artery disease and an implantable cardioverter defibrillator. Ann Noninvasive Electrocardiol. 2003;8(3):179–84.
Alter P, Grimm W, Vollrath A, Czerny F, Maisch B. Heart rate variability in patients with cardiac hypertrophy–relation to left ventricular mass and etiology. Am Heart J. 2006;151(4):829–36.
Debono M, Cachia E. The impact of cardiovascular autonomic neuropathy in diabetes: is it associated with left ventricular dysfunction? Auton Neurosci. 2007;132(1–2):1–7.
Just H. Peripheral adaptations in congestive heart failure: a review. Am J Med. 1991;90:23S–6.
Nakamura K, Matsumura K, Kobayashi S, Kaneko T. Sympathetic premotor neurons mediating thermoregulatory functions. Neurosci Res. 2005;51(1):1–8.
Manfrini O, Morgagni G, Pizzi C, Fontana F, Bugiardini R. Changes in autonomic nervous system activity: spontaneous versus balloon-induced myocardial ischaemia. Eur Heart J. 2004;25(17):1502–8.
Ahrens EH. Drugs spotlight program: the management of hyperlipidemia: whether, rather than how. Ann Intern Med. 1976;85(1):87–93.
Kumar V (editor), Abbas AK, Fausto N, Mitchell RS. Robbins basic pathology. 8th ed. Philadelphia: Saunders Elsevier; 2007.
Boyd G, Stout D, Aultman M, Wyatt K, Vetter T. Are there reliable clinical predictors of cardiac autonomic neuropathy in diabetic patients? American Society of Anesthesiologists, Annual Meeting, San Diego; 16–20 Oct 2010a.
Boyd G, Stout D, Morris R, Witherspoon CD, Vetter T. et al. Prevalence and severity of autonomic dysfunction in diabetic patients presenting for retinal surgery American Society of Anesthesiologists, Annual Meeting, San Diego; 16–20 Oct 2010b.
Umetani K, Singer DH, McCraty R, Atkinson M. Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J Am Coll Cardiol. 1998;31(3):593–601.
Low PA. Clinical autonomic disorders. 2nd ed. New York: Lippincott Press; 2006.
Clarke B, Ewing D, Campbell I. Diabetic autonomic neuropathy. Diabetologia. 1979;17:195–212.
Nanavati S, Bulgarelli RJ, Vazquez-Tanus J, Ghosh-Dastidar S, Colombo J, Arora RR. Altered autonomic activity with atrial fibrillation as demonstrated by non-invasive autonomic monitoring. American Autonomic Society, 17th International Symposium. Kauai;. 29 Oct–1 Nov 2008.
Tsuji H, Venditti Jr FJ, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90(2):878–83.
Cohn JN, Tognoni G, for the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker Valsartan in chronic heart failure. N Engl J Med. 2001;345:1667–75.
Malik M, and the Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability, standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17:354–81
Parati G, Valentini M. Prognostic relevance of blood pressure variability. Hypertension. 2006;47(2):137–8.
Parati G, Mancia G. Blood pressure variability as a risk factor. Blood Press Monit. 2001;6(6):341–7.
Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension. 1995;25(6):1276–86.
Parati G, Bilo G, Vettorello M, Groppelli A, Maronati A, Tortorici E, Caldara G, Mancia G. Assessment of overall blood pressure variability and its different components. Blood Press Monit. 2003;8(4):155–9.
Bilo G, Giglio A, Styczkiewicz K, Caldara G, Kawecka-Jaszcz K, Mancia G, Parati G. How to improve the assessment of 24-h blood pressure variability. Blood Press Monit. 2005;10(6):321–3.
Parati G, Rizzoni D. Assessing the prognostic relevance of blood pressure variability: discrepant information from different indices. J Hypertens. 2005;23(3):483–6.
Parati G, Di Rienzo M. Determinants of heart rate and heart rate variability. J Hypertens. 2003;21(3):477–80.
Parati G, Frattola A, Di Rienzo M, Mancia G. Blood pressure variability. Importance in research and in clinical hypertension. Arq Bras Cardiol. 1996;67(2):131–3.
Akselrod S, Gordon S, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuations: a quantitative probe of beat-to- beat cardiovascular control. Science. 1981;213:213–20.
Akselrod S, Gordon D, Madwed JB, Snidman NC, Shannon DC, Cohen RJ. Hemodynamic regulation: investigation by spectra analysis. Am J Physiol. 1985;249:H867–75.
Akselrod S, Eliash S, Oz O, Cohen S. Hemodynamic regulation in SHR: investigation by spectral analysis. Am J Physiol. 1987;253:H176–83.
Aysin B, Aysin E. Effect of respiration in heart rate variability (HRV) analysis. Conf Proc IEEE Eng Med Biol Soc. 2006;1:1776–9. PubMed: 17946068.
Aysin B, Aysin E, Colombo J Comparison of HRV analysis methods during orthostatic challenge: HRV with respiration or without? IEEE engineering in medicine and biology conference, Lyons: 2007.
Salpeter SR. Bronchodilators in COPD: impact of β-agonists and anticholinergics on severe exacerbations and mortality. Int J COPD. 2007;2(1):11–8.
de Vries F, Pouwels S, Bracke M, Lammers J, Klungel O, Leufkens H, van Staal T. Use of beta-2 agonists and risk of acute myocardial infarction in patients with hypertension. Br J Clin Pharmacol. 2008;65(4):580–6.
Faulkner MA, Hilleman DE. Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future. Pharmacotherapy. 2003;23(10):1300–15.
Cazzola M, Matera MG, Donner CF. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs. 2005;65(12):1595–610.
Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Meta-analysis: Effect of long-acting β -agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006;144:904–12.
Gupta P, O’Mahony MS. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Drug Aging. 2008;25(5):415–43.
Salpeter SR, Aaron SD. Rebuttal: Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? Can Fam Physician. 2007;53:1429–30.
Salpeter SR. Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES. Can Fam Physician. 2007;53(8):1290–7.
Salpeter SR. An update on the safety of long-acting beta-agonists in asthma patients using inhaled corticosteroids. Expert Opin Drug Saf. 2010;9(3):407–19.